Risk factors for stunting among children under five years: a cross-sectional population-based study in Rwanda using the 2015 Demographic and Health Survey.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
11 Feb 2019
Historique:
received: 06 08 2018
accepted: 01 02 2019
entrez: 13 2 2019
pubmed: 13 2 2019
medline: 13 3 2019
Statut: epublish

Résumé

Child growth stunting remains a challenge in sub-Saharan Africa, where 34% of children under 5 years are stunted, and causing detrimental impact at individual and societal levels. Identifying risk factors to stunting is key to developing proper interventions. This study aimed at identifying risk factors of stunting in Rwanda. We used data from the Rwanda Demographic and Health Survey (DHS) 2014-2015. Association between children's characteristics and stunting was assessed using logistic regression analysis. A total of 3594 under 5 years were included; where 51% of them were boys. The prevalence of stunting was 38% (95% CI: 35.92-39.52) for all children. In adjusted analysis, the following factors were significant: boys (OR 1.51; 95% CI 1.25-1.82), children ages 6-23 months (OR 4.91; 95% CI 3.16-7.62) and children ages 24-59 months (OR 6.34; 95% CI 4.07-9.89) compared to ages 0-6 months, low birth weight (OR 2.12; 95% CI 1.39-3.23), low maternal height (OR 3.27; 95% CI 1.89-5.64), primary education for mothers (OR 1.71; 95% CI 1.25-2.34), illiterate mothers (OR 2.00; 95% CI 1.37-2.92), history of not taking deworming medicine during pregnancy (OR 1.29; 95%CI 1.09-1.53), poorest households (OR 1.45; 95% CI 1.12-1.86; and OR 1.82; 95%CI 1.45-2.29 respectively). Family-level factors are major drivers of children's growth stunting in Rwanda. Interventions to improve the nutrition of pregnant and lactating women so as to prevent low birth weight babies, reduce poverty, promote girls' education and intervene early in cases of malnutrition are needed.

Sections du résumé

BACKGROUND BACKGROUND
Child growth stunting remains a challenge in sub-Saharan Africa, where 34% of children under 5 years are stunted, and causing detrimental impact at individual and societal levels. Identifying risk factors to stunting is key to developing proper interventions. This study aimed at identifying risk factors of stunting in Rwanda.
METHODS METHODS
We used data from the Rwanda Demographic and Health Survey (DHS) 2014-2015. Association between children's characteristics and stunting was assessed using logistic regression analysis.
RESULTS RESULTS
A total of 3594 under 5 years were included; where 51% of them were boys. The prevalence of stunting was 38% (95% CI: 35.92-39.52) for all children. In adjusted analysis, the following factors were significant: boys (OR 1.51; 95% CI 1.25-1.82), children ages 6-23 months (OR 4.91; 95% CI 3.16-7.62) and children ages 24-59 months (OR 6.34; 95% CI 4.07-9.89) compared to ages 0-6 months, low birth weight (OR 2.12; 95% CI 1.39-3.23), low maternal height (OR 3.27; 95% CI 1.89-5.64), primary education for mothers (OR 1.71; 95% CI 1.25-2.34), illiterate mothers (OR 2.00; 95% CI 1.37-2.92), history of not taking deworming medicine during pregnancy (OR 1.29; 95%CI 1.09-1.53), poorest households (OR 1.45; 95% CI 1.12-1.86; and OR 1.82; 95%CI 1.45-2.29 respectively).
CONCLUSION CONCLUSIONS
Family-level factors are major drivers of children's growth stunting in Rwanda. Interventions to improve the nutrition of pregnant and lactating women so as to prevent low birth weight babies, reduce poverty, promote girls' education and intervene early in cases of malnutrition are needed.

Identifiants

pubmed: 30744614
doi: 10.1186/s12889-019-6504-z
pii: 10.1186/s12889-019-6504-z
pmc: PMC6371425
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

175

Subventions

Organisme : Harvard Medical School Global Health Research Core
ID : NA
Organisme : Harvard Medical School Global Health Equity Research Fellowship, funded by Jonathan M. Goldstein and Kaia Miller Goldstein
ID : NA

Références

Indian Pediatr. 1994 Oct;31(10):1205-12
pubmed: 7875780
BMC Pediatr. 2014 Sep 27;14:239
pubmed: 25262003
BMC Pediatr. 2013 Aug 28;13:131
pubmed: 23981670
BMC Pediatr. 2007 Apr 10;7:17
pubmed: 17425787
Lancet. 2005 Nov 19;366(9499):1804-7
pubmed: 16298218
J Health Econ. 2003 Mar;22(2):271-93
pubmed: 12606146
World Health Organ Tech Rep Ser. 1995;854:1-452
pubmed: 8594834
Matern Child Nutr. 2013 Sep;9 Suppl 2:27-45
pubmed: 24074316
J Coll Physicians Surg Pak. 2006 Aug;16(8):529-31
pubmed: 16899182
BMC Public Health. 2017 Aug 1;18(1):74
pubmed: 28764669
Trop Med Int Health. 2015 Jan;20(1):17-23
pubmed: 25345559
Cochrane Database Syst Rev. 2019 Jun 17;6:CD011695
pubmed: 31204795
Acta Paediatr. 2001 Nov;90(11):1304-8
pubmed: 11808904
Matern Child Nutr. 2017 Apr;13(2):
pubmed: 27126511
J Pediatr. 2013 Aug;163(2):549-54
pubmed: 23477997
Am J Hum Biol. 2014 Jul-Aug;26(4):481-90
pubmed: 24706334
Lancet. 2017 Jan 7;389(10064):77-90
pubmed: 27717614
Public Health Nutr. 2000 Mar;3(1):39-47
pubmed: 10786722
Bull World Health Organ. 2013 May 1;91(5):341-9
pubmed: 23678197
PLoS Med. 2016 Nov 1;13(11):e1002164
pubmed: 27802277
Int J Epidemiol. 1996 Aug;25(4):693-703
pubmed: 8921445
Int J Epidemiol. 1997 Apr;26(2):349-56
pubmed: 9169170
JAMA. 2009 Apr 22;301(16):1691-701
pubmed: 19383960
Lancet. 2007 Jan 6;369(9555):60-70
pubmed: 17208643
Lancet. 2013 Aug 3;382(9890):452-477
pubmed: 23746776
Am J Hum Biol. 2009 Sep-Oct;21(5):657-63
pubmed: 19214997
Food Nutr Bull. 2017 Dec;38(4):542-553
pubmed: 28978233
Malays J Nutr. 2011 Apr;17(1):105-18
pubmed: 22135870
Eur J Clin Nutr. 1994 Feb;48 Suppl 1:S45-57
pubmed: 8005090
J Health Popul Nutr. 2006 Mar;24(1):89-99
pubmed: 16796155
J Biosoc Sci. 2007 Mar;39(2):161-73
pubmed: 16566847
Nutr Res. 2011 Oct;31(10):741-7
pubmed: 22074798
Nutrients. 2017 May 12;9(5):
pubmed: 28498315
Am J Clin Nutr. 2016 Jul;104(1):104-12
pubmed: 27357091
Int J Epidemiol. 2012 Dec;41(6):1602-13
pubmed: 23148108

Auteurs

Alphonse Nshimyiryo (A)

Partners In Health / Inshuti Mu Buzima, Kigali, Rwanda. anshimyiryo@pih.org.

Bethany Hedt-Gauthier (B)

Partners In Health / Inshuti Mu Buzima, Kigali, Rwanda.
Department of Global Health and Social Medicine, Harvard Medical School, Boston, USA.
Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, USA.

Christine Mutaganzwa (C)

Partners In Health / Inshuti Mu Buzima, Kigali, Rwanda.

Catherine M Kirk (CM)

Partners In Health / Inshuti Mu Buzima, Kigali, Rwanda.

Kathryn Beck (K)

Partners In Health / Inshuti Mu Buzima, Kigali, Rwanda.

Albert Ndayisaba (A)

Partners In Health / Inshuti Mu Buzima, Kigali, Rwanda.

Joel Mubiligi (J)

Partners In Health / Inshuti Mu Buzima, Kigali, Rwanda.

Fredrick Kateera (F)

Partners In Health / Inshuti Mu Buzima, Kigali, Rwanda.

Ziad El-Khatib (Z)

Partners In Health / Inshuti Mu Buzima, Kigali, Rwanda.
Department of Global Health and Social Medicine, Harvard Medical School, Boston, USA.
Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden.
World Health Programme, Université du Québec en Abitibi-Témiscamingue (UQAT), Québec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH